{
  "compound": "Cannabis extract (oral)",
  "condition": "PARKINSONS",
  "effect_size": "Small (d = 0.24)",
  "study_type": "RCT",
  "source": "NORML:PD_RCT_005",
  "participants": "19 PD patients with motor fluctuations",
  "year": 2004,
  "notes": "Nabiximols for Parkinson's Disease Motor Fluctuations: Pilot RCT",
  "confidence": "medium",
  "abstract": "No significant difference in dyskinesia score; Trend toward improvement in OFF time (18% reduction)"
}